<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>12-lipoxygenase (12-LOX) pathway which produces <z:chebi fb="0" ids="19138">12-HETE</z:chebi> and hepoxiline HXA3 and HXB3, and induces production of reactive oxygen species and <z:mp ids='MP_0001845'>inflammation</z:mp> is increasingly being implicated in variety of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e>, including those of colorectal and <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Hence, we examined whether the functional polymorphism of 12-LOX (<z:chebi fb="2" ids="33699">mRNA</z:chebi> A835G; Protein Gln261Arg) has any association with human colorectal and <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancers</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In this communication, we report that the mutation is linked to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Further, we also observed that the heterozygous mutant (AG) is more prevalent in females than in males </plain></SENT>
<SENT sid="4" pm="."><plain>Frequencies of AA, AG and GG, respectively were 62.5, 36.2 and 1.3 % in controls, 36.5, 61.5 and 2.0 % in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases and 35.6, 62.4 and 2.0 % in <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancer</z:e> cases </plain></SENT>
<SENT sid="5" pm="."><plain>The results obtained suggested a significant association of the heterogenous variant (AG) with the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Relative risk of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> with the presence of the AG variant was found to be 2.9 and 4.0 for colorectal and <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancers</z:e>, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>However, the association of the variant (AG) was significant only in male <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients but not in female patients </plain></SENT>
<SENT sid="8" pm="."><plain>On the other hand, prevalence of the AG variant is significantly higher in control females than in male control subjects </plain></SENT>
<SENT sid="9" pm="."><plain>To the best of our knowledge, this is the first study that links the 12-LOX gene polymorphism with <z:e sem="disease" ids="C0007115" disease_type="Neoplastic Process" abbrv="">thyroid cancer</z:e> and reveals a gender bias in the prevalence of the polymorphic variants in controls and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
</text></document>